Novel Gene Therapies for Cystic Fibrosis Continue to Shape Future Global Market

  • RSS Feed

- by Denise Lymperis, Head of Genitourinary and Rare Disorders for GlobalData

Last week in the UK, a groundbreaking gene therapy trial for cystic fibrosis (CF) was announced. This serves as yet another strong indicator that pharmaceutical and biotech companies are increasingly moving into the market with treatments that target the underlying cause of the disease, rather than just the symptoms.

Gain full access to this article

You must register to read the full Expert Insight article. Register for FREE today and access all our healthcare Expert Insights.


Registering for our Expert Insights is free and only takes a moment.

Following this you'll gain unlimited access to all of the latest, event-driven opinion put together by our teams of experienced analysts.

Send to a colleague


© GlobalData 2015. John Carpenter House, 7 Carmelite Street, London EC4 0BS.